Comparison of the characteristics of the population eligible for lung cancer screening under 2013 and population newly eligible under 2021 US Preventive Services Task Force recommendations
Purpose In 2021, the United States Preventive Services Task Force (USPSTF) revised their 2013 recommendations for lung cancer screening eligibility by lowering the pack-year history from 30+ to 20+ pack-years and the recommended age from 55 to 50 years. Simulation studies suggest that Black persons...
Gespeichert in:
| Veröffentlicht in: | Cancer causes & control 2024-09, Vol.35 (9), p.1233-1243 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1243 |
|---|---|
| container_issue | 9 |
| container_start_page | 1233 |
| container_title | Cancer causes & control |
| container_volume | 35 |
| creator | Yell, Nicholas Eberth, Jan M. Alberg, Anthony J. Hung, Peiyin Schootman, Mario McLain, Alexander C. Munden, Reginald F. |
| description | Purpose
In 2021, the United States Preventive Services Task Force (USPSTF) revised their 2013 recommendations for lung cancer screening eligibility by lowering the pack-year history from 30+ to 20+ pack-years and the recommended age from 55 to 50 years. Simulation studies suggest that Black persons and females will benefit most from these changes, but it is unclear how the revised USPSTF recommendations will impact geographic, health-related, and other sociodemographic characteristics of those eligible.
Methods
This cross-sectional study employed data from the 2017–2020 Behavioral Risk Factor Surveillance System surveys from 23 states to compare age, gender, race, marital, sexual orientation, education, employment, comorbidity, vaccination, region, and rurality characteristics of the eligible population according to the original 2013 USPSTF recommendations with the revised 2021 USPSTF recommendations using chi-squared tests. This study compared those originally eligible to those newly eligible using the BRFSS raking-dervived weighting variable.
Results
There were 30,190 study participants. The results of this study found that eligibility increased by 62.4% due to the revised recommendations. We found that the recommendation changes increased the proportion of eligible females (50.1% vs 44.1%), Black persons (9.2% vs 6.6%), Hispanic persons (4.4% vs 2.7%), persons aged 55–64 (55.8% vs 52.6%), urban-dwellers(88.3% vs 85.9%), unmarried (3.4% vs 2.5%) and never married (10.4% vs 6.6%) persons, as well as non-retirees (76.5% vs 56.1%) Respondents without comorbidities and COPD also increased.
Conclusion
It is estimated that the revision of the lung cancer screening recommendations decreased eligibility disparities in sex, race, ethnicity, marital status, respiratory comorbidities, and vaccination status. Research will be necessary to estimate whether uptake patterns subsequently follow the expanded eligibility patterns. |
| doi_str_mv | 10.1007/s10552-024-01880-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3052595296</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3052595296</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-5df2f5ac1914bdeb957220b3082f08c584428415b713f8e85a8a8086e1f2e3dd3</originalsourceid><addsrcrecordid>eNp9kc9u3CAQh1HVqtkmfYEeKqReenE7gFnYY7XKn0qRGinJGWE83pDa4IK9Vd6tD1eSzTZVDhEHxPDNN4gfIR8YfGEA6mtmICWvgNcVMK2hWr4iCyaVqBTn8jVZwEqqSvJaHJB3Od8CgFxyeEsOhFZMKS4W5M86DqNNPsdAY0enG6TuxibrJizFybu8L49xnHs7-QJi7ze-6ZF2MdF-DhvqbHCYaHYJMfhSmENbzhyYoDa0_zcH_N3fPSn2IGf0-pJeJNximPwW6SWmrXeY6ZXNP-lJTA5pQheHAUP7oMpH5E1n-4zvH_dDcn1yfLU-q85_nH5ffzuvnFAwVbLteCetYytWNy025Vc4h0aA5h1oJ3Vdc10z2SgmOo1aWm016CWyjqNoW3FIPu-8Y4q_ZsyTGXx22Pc2YJyzESC5XEm-Whb00zP0Ns4plNcZwaAsWUtWKL6jXIo5J-zMmPxg051hYO6zNbtsTcnWPGRr7tUfH9VzM2D7r2UfZgHEDsjlKmwwPc1-QfsXi06xCg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3101015451</pqid></control><display><type>article</type><title>Comparison of the characteristics of the population eligible for lung cancer screening under 2013 and population newly eligible under 2021 US Preventive Services Task Force recommendations</title><source>SpringerNature Journals</source><creator>Yell, Nicholas ; Eberth, Jan M. ; Alberg, Anthony J. ; Hung, Peiyin ; Schootman, Mario ; McLain, Alexander C. ; Munden, Reginald F.</creator><creatorcontrib>Yell, Nicholas ; Eberth, Jan M. ; Alberg, Anthony J. ; Hung, Peiyin ; Schootman, Mario ; McLain, Alexander C. ; Munden, Reginald F.</creatorcontrib><description>Purpose
In 2021, the United States Preventive Services Task Force (USPSTF) revised their 2013 recommendations for lung cancer screening eligibility by lowering the pack-year history from 30+ to 20+ pack-years and the recommended age from 55 to 50 years. Simulation studies suggest that Black persons and females will benefit most from these changes, but it is unclear how the revised USPSTF recommendations will impact geographic, health-related, and other sociodemographic characteristics of those eligible.
Methods
This cross-sectional study employed data from the 2017–2020 Behavioral Risk Factor Surveillance System surveys from 23 states to compare age, gender, race, marital, sexual orientation, education, employment, comorbidity, vaccination, region, and rurality characteristics of the eligible population according to the original 2013 USPSTF recommendations with the revised 2021 USPSTF recommendations using chi-squared tests. This study compared those originally eligible to those newly eligible using the BRFSS raking-dervived weighting variable.
Results
There were 30,190 study participants. The results of this study found that eligibility increased by 62.4% due to the revised recommendations. We found that the recommendation changes increased the proportion of eligible females (50.1% vs 44.1%), Black persons (9.2% vs 6.6%), Hispanic persons (4.4% vs 2.7%), persons aged 55–64 (55.8% vs 52.6%), urban-dwellers(88.3% vs 85.9%), unmarried (3.4% vs 2.5%) and never married (10.4% vs 6.6%) persons, as well as non-retirees (76.5% vs 56.1%) Respondents without comorbidities and COPD also increased.
Conclusion
It is estimated that the revision of the lung cancer screening recommendations decreased eligibility disparities in sex, race, ethnicity, marital status, respiratory comorbidities, and vaccination status. Research will be necessary to estimate whether uptake patterns subsequently follow the expanded eligibility patterns.</description><identifier>ISSN: 0957-5243</identifier><identifier>ISSN: 1573-7225</identifier><identifier>EISSN: 1573-7225</identifier><identifier>DOI: 10.1007/s10552-024-01880-6</identifier><identifier>PMID: 38717723</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Black people ; Cancer Research ; Cancer screening ; Chronic obstructive pulmonary disease ; Comorbidity ; Epidemiology ; Hematology ; Immunization ; Lung cancer ; Medical screening ; Oncology ; Original Paper ; Public Health ; Respiration ; Risk factors ; Sexual behavior ; Task forces ; Vaccination</subject><ispartof>Cancer causes & control, 2024-09, Vol.35 (9), p.1233-1243</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c370t-5df2f5ac1914bdeb957220b3082f08c584428415b713f8e85a8a8086e1f2e3dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10552-024-01880-6$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10552-024-01880-6$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38717723$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yell, Nicholas</creatorcontrib><creatorcontrib>Eberth, Jan M.</creatorcontrib><creatorcontrib>Alberg, Anthony J.</creatorcontrib><creatorcontrib>Hung, Peiyin</creatorcontrib><creatorcontrib>Schootman, Mario</creatorcontrib><creatorcontrib>McLain, Alexander C.</creatorcontrib><creatorcontrib>Munden, Reginald F.</creatorcontrib><title>Comparison of the characteristics of the population eligible for lung cancer screening under 2013 and population newly eligible under 2021 US Preventive Services Task Force recommendations</title><title>Cancer causes & control</title><addtitle>Cancer Causes Control</addtitle><addtitle>Cancer Causes Control</addtitle><description>Purpose
In 2021, the United States Preventive Services Task Force (USPSTF) revised their 2013 recommendations for lung cancer screening eligibility by lowering the pack-year history from 30+ to 20+ pack-years and the recommended age from 55 to 50 years. Simulation studies suggest that Black persons and females will benefit most from these changes, but it is unclear how the revised USPSTF recommendations will impact geographic, health-related, and other sociodemographic characteristics of those eligible.
Methods
This cross-sectional study employed data from the 2017–2020 Behavioral Risk Factor Surveillance System surveys from 23 states to compare age, gender, race, marital, sexual orientation, education, employment, comorbidity, vaccination, region, and rurality characteristics of the eligible population according to the original 2013 USPSTF recommendations with the revised 2021 USPSTF recommendations using chi-squared tests. This study compared those originally eligible to those newly eligible using the BRFSS raking-dervived weighting variable.
Results
There were 30,190 study participants. The results of this study found that eligibility increased by 62.4% due to the revised recommendations. We found that the recommendation changes increased the proportion of eligible females (50.1% vs 44.1%), Black persons (9.2% vs 6.6%), Hispanic persons (4.4% vs 2.7%), persons aged 55–64 (55.8% vs 52.6%), urban-dwellers(88.3% vs 85.9%), unmarried (3.4% vs 2.5%) and never married (10.4% vs 6.6%) persons, as well as non-retirees (76.5% vs 56.1%) Respondents without comorbidities and COPD also increased.
Conclusion
It is estimated that the revision of the lung cancer screening recommendations decreased eligibility disparities in sex, race, ethnicity, marital status, respiratory comorbidities, and vaccination status. Research will be necessary to estimate whether uptake patterns subsequently follow the expanded eligibility patterns.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Black people</subject><subject>Cancer Research</subject><subject>Cancer screening</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Comorbidity</subject><subject>Epidemiology</subject><subject>Hematology</subject><subject>Immunization</subject><subject>Lung cancer</subject><subject>Medical screening</subject><subject>Oncology</subject><subject>Original Paper</subject><subject>Public Health</subject><subject>Respiration</subject><subject>Risk factors</subject><subject>Sexual behavior</subject><subject>Task forces</subject><subject>Vaccination</subject><issn>0957-5243</issn><issn>1573-7225</issn><issn>1573-7225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp9kc9u3CAQh1HVqtkmfYEeKqReenE7gFnYY7XKn0qRGinJGWE83pDa4IK9Vd6tD1eSzTZVDhEHxPDNN4gfIR8YfGEA6mtmICWvgNcVMK2hWr4iCyaVqBTn8jVZwEqqSvJaHJB3Od8CgFxyeEsOhFZMKS4W5M86DqNNPsdAY0enG6TuxibrJizFybu8L49xnHs7-QJi7ze-6ZF2MdF-DhvqbHCYaHYJMfhSmENbzhyYoDa0_zcH_N3fPSn2IGf0-pJeJNximPwW6SWmrXeY6ZXNP-lJTA5pQheHAUP7oMpH5E1n-4zvH_dDcn1yfLU-q85_nH5ffzuvnFAwVbLteCetYytWNy025Vc4h0aA5h1oJ3Vdc10z2SgmOo1aWm016CWyjqNoW3FIPu-8Y4q_ZsyTGXx22Pc2YJyzESC5XEm-Whb00zP0Ns4plNcZwaAsWUtWKL6jXIo5J-zMmPxg051hYO6zNbtsTcnWPGRr7tUfH9VzM2D7r2UfZgHEDsjlKmwwPc1-QfsXi06xCg</recordid><startdate>20240901</startdate><enddate>20240901</enddate><creator>Yell, Nicholas</creator><creator>Eberth, Jan M.</creator><creator>Alberg, Anthony J.</creator><creator>Hung, Peiyin</creator><creator>Schootman, Mario</creator><creator>McLain, Alexander C.</creator><creator>Munden, Reginald F.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20240901</creationdate><title>Comparison of the characteristics of the population eligible for lung cancer screening under 2013 and population newly eligible under 2021 US Preventive Services Task Force recommendations</title><author>Yell, Nicholas ; Eberth, Jan M. ; Alberg, Anthony J. ; Hung, Peiyin ; Schootman, Mario ; McLain, Alexander C. ; Munden, Reginald F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-5df2f5ac1914bdeb957220b3082f08c584428415b713f8e85a8a8086e1f2e3dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Black people</topic><topic>Cancer Research</topic><topic>Cancer screening</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Comorbidity</topic><topic>Epidemiology</topic><topic>Hematology</topic><topic>Immunization</topic><topic>Lung cancer</topic><topic>Medical screening</topic><topic>Oncology</topic><topic>Original Paper</topic><topic>Public Health</topic><topic>Respiration</topic><topic>Risk factors</topic><topic>Sexual behavior</topic><topic>Task forces</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yell, Nicholas</creatorcontrib><creatorcontrib>Eberth, Jan M.</creatorcontrib><creatorcontrib>Alberg, Anthony J.</creatorcontrib><creatorcontrib>Hung, Peiyin</creatorcontrib><creatorcontrib>Schootman, Mario</creatorcontrib><creatorcontrib>McLain, Alexander C.</creatorcontrib><creatorcontrib>Munden, Reginald F.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer causes & control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yell, Nicholas</au><au>Eberth, Jan M.</au><au>Alberg, Anthony J.</au><au>Hung, Peiyin</au><au>Schootman, Mario</au><au>McLain, Alexander C.</au><au>Munden, Reginald F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the characteristics of the population eligible for lung cancer screening under 2013 and population newly eligible under 2021 US Preventive Services Task Force recommendations</atitle><jtitle>Cancer causes & control</jtitle><stitle>Cancer Causes Control</stitle><addtitle>Cancer Causes Control</addtitle><date>2024-09-01</date><risdate>2024</risdate><volume>35</volume><issue>9</issue><spage>1233</spage><epage>1243</epage><pages>1233-1243</pages><issn>0957-5243</issn><issn>1573-7225</issn><eissn>1573-7225</eissn><abstract>Purpose
In 2021, the United States Preventive Services Task Force (USPSTF) revised their 2013 recommendations for lung cancer screening eligibility by lowering the pack-year history from 30+ to 20+ pack-years and the recommended age from 55 to 50 years. Simulation studies suggest that Black persons and females will benefit most from these changes, but it is unclear how the revised USPSTF recommendations will impact geographic, health-related, and other sociodemographic characteristics of those eligible.
Methods
This cross-sectional study employed data from the 2017–2020 Behavioral Risk Factor Surveillance System surveys from 23 states to compare age, gender, race, marital, sexual orientation, education, employment, comorbidity, vaccination, region, and rurality characteristics of the eligible population according to the original 2013 USPSTF recommendations with the revised 2021 USPSTF recommendations using chi-squared tests. This study compared those originally eligible to those newly eligible using the BRFSS raking-dervived weighting variable.
Results
There were 30,190 study participants. The results of this study found that eligibility increased by 62.4% due to the revised recommendations. We found that the recommendation changes increased the proportion of eligible females (50.1% vs 44.1%), Black persons (9.2% vs 6.6%), Hispanic persons (4.4% vs 2.7%), persons aged 55–64 (55.8% vs 52.6%), urban-dwellers(88.3% vs 85.9%), unmarried (3.4% vs 2.5%) and never married (10.4% vs 6.6%) persons, as well as non-retirees (76.5% vs 56.1%) Respondents without comorbidities and COPD also increased.
Conclusion
It is estimated that the revision of the lung cancer screening recommendations decreased eligibility disparities in sex, race, ethnicity, marital status, respiratory comorbidities, and vaccination status. Research will be necessary to estimate whether uptake patterns subsequently follow the expanded eligibility patterns.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>38717723</pmid><doi>10.1007/s10552-024-01880-6</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0957-5243 |
| ispartof | Cancer causes & control, 2024-09, Vol.35 (9), p.1233-1243 |
| issn | 0957-5243 1573-7225 1573-7225 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3052595296 |
| source | SpringerNature Journals |
| subjects | Biomedical and Life Sciences Biomedicine Black people Cancer Research Cancer screening Chronic obstructive pulmonary disease Comorbidity Epidemiology Hematology Immunization Lung cancer Medical screening Oncology Original Paper Public Health Respiration Risk factors Sexual behavior Task forces Vaccination |
| title | Comparison of the characteristics of the population eligible for lung cancer screening under 2013 and population newly eligible under 2021 US Preventive Services Task Force recommendations |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T19%3A18%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20characteristics%20of%20the%20population%20eligible%20for%20lung%20cancer%20screening%20under%202013%20and%20population%20newly%20eligible%20under%202021%20US%20Preventive%20Services%20Task%20Force%20recommendations&rft.jtitle=Cancer%20causes%20&%20control&rft.au=Yell,%20Nicholas&rft.date=2024-09-01&rft.volume=35&rft.issue=9&rft.spage=1233&rft.epage=1243&rft.pages=1233-1243&rft.issn=0957-5243&rft.eissn=1573-7225&rft_id=info:doi/10.1007/s10552-024-01880-6&rft_dat=%3Cproquest_cross%3E3052595296%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3101015451&rft_id=info:pmid/38717723&rfr_iscdi=true |